Cellular immune dysfunction in immune thrombocytopenia (ITP)

British Journal of Haematology

Volumn 163, Issue 1, 2013, Pages 10-23

  Mckenzie, Christopher G J ^a,b   Guo, Li ^a,b,c   Freedman, John ^a,c   Semple, John W ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antigen presenting cells; Autoimmunity; B cells; Immune thrombocytopenia (ITP); T cells

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RITUXIMAB;

ANTIBODY RESPONSE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CELLULAR IMMUNE DYSFUNCTION; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG MECHANISM; DRUG MEGADOSE; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; IMMUNE THROMBOCYTOPENIA; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THROMBOCYTOPENIA;

ANTIGEN PRESENTING CELLS; AUTOIMMUNITY; B CELLS; IMMUNE THROMBOCYTOPENIA (ITP); T CELLS;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84884152225     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12480     Document Type: Review

References (191)

1. Abdel-Hamid, S.M. & Al-Lithy, H.N. (2011) B cell activating factor gene polymorphisms in patients with risk of idiopathic thrombocytopenic purpura. American Journal of the Medical Sciences, 1, 9-14.
2. Aboul-Fotoh Lel, M., Abdel Raheem, M.M., El-Deen, M.A. & Osman, A.M. (2011) Role of CD4 + CD25 + T cells in children with idiopathic thrombocytopenic purpura. Journal of Pediatric Hematology/Oncology, 2, 81-85.
3. Abudureheman, A., Yasen, H., Fang, Z., Xue, Z., Jian-bing, D., Xiu-min, M. & Xin-hong, G. (2010) Expression of CD4 + CD25 + regulatory T cells and TGF-ß1 in patient with idiopathic thrombocytopenic purpura. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 9, 895-897.
4. Afzali, B., Lombardi, G., Lechler, R.I. & Lord, G.M. (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology, 1, 32-46.
5. Akira, S. & Hemmi, H. (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunology Letters, 2, 85-95.
6. Amodio, G. & Gregori, S. (2012) Dendritic cells a double-edge sword in autoimmune responses. Frontiers in Immunology, 3, 233.
7. Andonegui, G., Kerfoot, S.M., McNagny, K., Ebbert, K.V., Patel, K.D. & Kubes, P. (2005) Platelets express functional Toll-like receptor-4. Blood, 7, 2417-2423.
8. André, S., Tough, D.F., Lacroix-Desmazes, S., Kaveri, S.V. & Bayry, J. (2009) Surveillance of antigen-presenting cells by CD4 + CD25 + regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. American Journal of Pathology, 5, 1575-1587.
9. Anis, S.K., Abdel Ghany, E.A., Mostafa, N.O. & Ali, A.A. (2011) The role of PTPN22 gene polymorphism in childhood immune thrombocytopenic purpura. Blood Coagulation & Fibrinolysis, 6, 521-525.
10. Arkfeld, D.G. & Weitz, I.C. (2009) Immune thrombocytopenia in patients with connective tissue disorders and the antiphospholipid antibody syndrome. Hematology/Oncology Clinics of North America, 6, 1239-1249.
11. Aslam, R., Speck, E.R., Kim, M., Crow, A.R., Bang, K.W., Nestel, F.P., Ni, H., Lazarus, A.H., Freedman, J. & Semple, J.W. (2006) Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood, 2, 637-641.
12. Aslam, R., Hu, Y., Gebremeskel, S., Segel, G.B., Speck, E.R., Guo, L., Kim, M., Ni, H., Freedman, J. & Semple, J.W. (2012) Thymic retention of CD4 + CD25 + FoxP3 + T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood, 10, 2127-2132.
13. Audia, S., Samson, M., Guy, J., Janikashvili, N., Fraszczak, J., Trad, M., Ciudad, M., Leguy, V., Berthier, S., Petrella, T., Aho-Glélé, S., Martin, L., Maynadié, M., Lorcerie, B., Rat, P., Cheynel, N., Katsanis, E., Larmonier, N. & Bonnotte, B. (2011) Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Blood, 16, 4394-4400.
14. Aurrand-Lions, M., Galland, F., Bazin, H., Zakharyev, V.M., Imhof, B.A. & Naquet, P. (1996) Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Immunity, 5, 391-405.
15. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B. & Palucka, K. (2000) Immunobiology of dendritic cells. Annual Review of Immunology, 18, 767-811.
16. Bao, W., Bussel, J.B., Heck, S., He, W., Karpoff, M., Boulad, N. & Yazdanbakhsh, K. (2010) Improved regulatory T cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood, 22, 4639-4645.
17. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L. & Kuchroo, V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 7090, 235-238.
18. Blair, P.A., Noreña, L.Y., Flores-Borja, F., Rawlings, D.J., Isenberg, D.A., Ehrenstein, M.R. & Mauri, C. (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity, 1, 129-140.
19. Blanco, P., Palucka, A.K., Pascual, V. & Banchereau, J. (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine & Growth Factor Reviews, 1, 41-52.
20. Bowles, J.A., Wang, S.Y., Link, B.K., Allan, B., Beuerlein, G., Campbell, M.A., Marquis, D., Ondek, B., Wooldridge, J.E., Smith, B.J., Breitmeyer, J.B. & Weiner, G.J. (2006) Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood, 8, 2648-2654.
21. Bredlau, A.L., Semple, J.W. & Segel, G.B. (2011) Management of immune thrombocytopenic purpura in children: potential role of novel agents. Paediatric Drugs, 4, 213-223.
22. Bromley, S.K., Burack, W.R., Johnson, K.G., Somersalo, K., Sims, T.N., Sumen, C., Davis, M.M., Shaw, A.S., Allen, P.M. & Dustin, M.L. (2001) The immunological synapse. Annual Review of Immunology, 19, 375-396.
23. Buchanan, G.R. & Adix, L. (2006) Current challenges in the management of children with idiopathic thrombocytopenic purpura. Pediatric Blood & Cancer, 5, 681-684.
24. Cao, J., Chen, C., Zeng, L., Li, L., Li, X., Li, Z. & Xu, K. (2011a) Elevated plasma IL-22 levels correlated with Th1 and Th22 cells in patients with immune thrombocytopenia. Clinical Immunology, 1, 121-123.
25. Cao, J., Li, X.Q., Chen, C., Zeng, L.Y., Cheng, H., Li, Z.Y., Pang, X.Y. & Xu, K.L. (2011b) Imbalance of Th17/Treg cells ratio in peripheral blood of patients with immune thrombocytopenia. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 3, 730-733.
26. Cao, J., Chen, C., Li, L., Ling-yu, Z., Zhen-yu, L., Zhi-ling, Y., Wei, C., Hai, C., Sang, W. & Kai-lin, X. (2012) Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia. Journal of Clinical Immunology, 3, 523-529.
27. Catani, L., Fagioli, M.E., Tazzari, P.L., Ricci, F., Curti, A., Rovito, M., Preda, P., Chirumbolo, G., Amabile, M., Lemoli, R.M., Tura, S., Conte, R., Baccarani, M. & Vianelli, N. (2006) Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T cells. Experimental Hematology, 7, 879-887.
28. Catani, L., Sollazzo, D., Trabanelli, S., Curti, A., Evangelisti, C., Polverelli, N., Palandri, F., Baccarani, M., Vianelli, N. & Lemoli, R.M. (2013) Decreased expression of indoleamine 2, 3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. Annals of Hematology, 1, 67-78.
29. Chang, M., Nakagawa, P.A., Williams, S.A., Schwartz, M.R., Imfeld, K.L., Buzby, J.S. & Nugent, D.J. (2003) Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood, 3, 887-895.
30. Chang, D.Y., Ouyang, J., Zhou, R.F., Xu, J.Y., Chen, B., Yang, Y.G., Zhang, Q.G., Shao, X.Y., Guan, C.Y. & Xu, Y. (2010) Profiles of different subsets of CD(4)(+) T cells in chronic idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi, 3, 213-216.
31. Chaplin, D.D. (2010) Overview of the immune response. Journal of Allergy and Clinical Immunology, 125, S3-S23.
32. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G. & Wahl, S.M. (2003) Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3. Journal of Experimental Medicine, 12, 1875-1886.
33. Chen, Z.P., Gu, D.S., Zhou, Z.P., Chen, X.L., Guo, Z.X., Du, W.T., Ge, J., Ren, Q. & Yang, R.C. (2011) Decreased expression of MBD2 and MBD4 gene and genomic-wide hypomethylation in patients with primary immune thrombocytopenia. Human Immunology, 6, 486-491.
34. Chen, J.F., Yang, L.H., Chang, L.X., Feng, J.J. & Liu, J.Q. (2012) The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia. Hematology, 5, 283-290.
35. Chow, L., Aslam, R., Speck, E.R., Kim, M., Cridland, N., Webster, M.L., Chen, P., Sahib, K., Ni, H., Lazarus, A.H., Garvey, M.B., Freedman, J. & Semple, J.W. (2010) A murine model of severe immune thrombocytopenia is induced by antibody- and CD8 + T cell-mediated responses that are differentially sensitive to therapy. Blood, 6, 1247-1253.
36. Cines, D.B., Bussel, J.B., Liebman, H.A. & Luning Prak, E.T. (2009) The ITP syndrome: pathogenic and clinical diversity. Blood, 26, 6511-6521.
37. Coopamah, M.D., Garvey, M.B., Freedman, J. & Semple, J.W. (2003) Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update. Transfusion Medicine Reviews, 1, 69-80.
38. Crow, A.R., Song, S., Freedman, J., Helgason, C.D., Humphries, R.K., Siminovitch, K.A. & Lazarus, A.H. (2003) IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood, 2, 558-560.
39. Crow, A.R., Song, S., Semple, J.W., Freedman, J. & Lazarus, A.H. (2007) A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood, 1, 155-158.
40. Crow, A.R., Suppa, S.J., Chen, X., Mott, P.J. & Lazarus, A.H. (2011) The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia. Blood, 24, 6403-6406.
41. Cwirla, S.E., Balasubramanian, P., Duffin, D.J., Wagstrom, C.R., Gates, C.M., Singer, S.C., Davis, A.M., Tansik, R.L., Mattheakis, L.C., Boytos, C.M., Schatz, P.J., Baccanari, D.P., Wrighton, N.C., Barrett, R.W. & Dower, W.J. (1997) Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science, 5319, 1696-1699.
42. Daridon, C., Loddenkemper, C., Spieckermann, S., Kühl, A.A., Salama, A., Burmester, G.R., Lipsky, P.E. & Dörner, T. (2012) Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia. Blood, 25, 5021-5031.
43. David, R. (2009) Regulatory T cells: fine-tuning TReg cells. Nature Reviews Immunology, 9, 226-227.
44. DiPaolo, R.J., Brinster, C., Davidson, T.S., Andersson, J., Glass, D. & Shevach, E.M. (2007) Autoantigen-specific TGFbeta-induced Foxp3 + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. Journal of Immunology, 7, 4685-4693.
45. Duan, X.J., Yang, L.H., Zhang, L., Ren, F.G., Zhang, R.J., Chen, J.F., Qin, X.Y. & Liang, H.Z. (2012) Expressions of th17 cells and interleukin 17 in patients with primary immune thrombocytopenia and their clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 5, 1154-1157.
46. Eisenbeis, C.F., Grainger, A., Fischer, B., Baiocchi, R.A., Carrodeguas, L., Roychowdhury, S., Chen, L., Banks, A.L., Davis, T., Young, D., Kelbick, N., Stephens, J., Byrd, J.C., Grever, M.R., Caligiuri, M.A. & Porcu, P. (2004) Combination immunotherapy of B cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study. Clinical Cancer Research, 18, 6101-6110.
47. Emmerich, F., Bal, G., Barakat, A., Milz, J., Mühle, C., Martinez-Gamboa, L., Dörner, T. & Salama, A. (2007) High-level serum B cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. British Journal of Haematology, 2, 309-314.
48. Eyada, T.K., Farawela, H.M., Khorshied, M.M., Shaheen, I.A., Selim, N.M. & Khalifa, I.A. (2012) FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt. Blood Coagulation & Fibrinolysis, 1, 64-68.
49. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F., Odorisio, T., Traidl-Hoffmann, C., Behrendt, H., Durham, S.R., Schmidt-Weber, C.B. & Cavani, A. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. The Journal of Clinical Investigation, 12, 3573-3585.
50. Fahim, N.M. & Monir, E. (2006) Functional role of CD4 + CD25 + regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura. The Egyptian Journal of Immunology, 1, 173-187.
51. Feng, X., Scheinberg, P., Samsel, L., Rios, O., Chen, J., McCoy, J.P. Jr, Ghanima, W., Bussel, J.B. & Young, N.S. (2012) Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. Journal of Thrombosis and Haemostasis, 8, 1616-1623.
52. Filion, M.C., Bradley, A.J., Devine, D.V., Décary, F. & Chartrand, P. (1995) Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. European Journal of Immunology, 11, 3123-3127.
53. Garcia-Suarez, J., Prieto, A., Reyes, E., Manzano, L., Merino, J.L. & Alvarez-Mon, M. (1993) Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56 + CD3- natural killer cells subset. Blood, 5, 1538-1545.
54. Gilliet, M., Cao, W. & Liu, Y.J. (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nature Reviews Immunology, 8, 594-606.
55. Glennie, M.J., French, R.R., Cragg, M.S. & Taylor, R.P. (2007) Mechanisms of killing by anti-CD20 monoclonal antibodies. Molecular Immunology, 16, 3823-3837.
56. Gluck, W.L., Hurst, D., Yuen, A., Levine, A.M., Dayton, M.A., Gockerman, J.P., Lucas, J., Denis-Mize, K., Tong, B., Navis, D., Difrancesco, A., Milan, S., Wilson, S.E. & Wolin, M. (2004) Phase I studies of interleukin (IL)-2 and rituximab in B cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response. Clinical Cancer Research, 7, 2253-2264.
57. Golay, J., Manganini, M., Facchinetti, V., Gramigna, R., Broady, R., Borleri, G., Rambaldi, A. & Introna, M. (2003) Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. Haematologica, 9, 1002-1012.
58. Guo, N.H., Shi, Q.Z., Hua, J.Y., Li, Z.J., Li, J., He, W.F. & Wu, Q. (2010) Expression of regulatory T cells and Th17 cells in idiopathic thrombocytopenic purpura and its significance. Zhonghua Xue Ye Xue Za Zhi, 9, 610-612.
59. Guo, X.H., Zhao, F., Shi, W., Ma, X.M., Xu, Q., A-Bu-Li-Zi, P. & Ya-Sen, H. (2012) Detection and clinical significance of Th1/Th2 cytokines in patients with idiopathic thrombocytopenic purpura. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 11, 1185-1187.
60. Hammill, D. & Helton, M. (1981) Idiopathic thrombocytopenia in a mare. Modern Veterinary Practice, 5, 392.
61. Hansen, R.J. & Balthasar, J.P. (2002) Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. Thrombosis and Haemostasis, 6, 898-899.
62. Harrington, W.J., Minnich, V., Hollingsworth, J.W. & Moore, C.V. (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. Journal of Laboratory and Clinical Medicine, 1, 1-10.
63. Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M. & Weaver, C.T. (2005) Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology, 11, 1123-1132.
64. Hornung, V., Barchet, W., Schlee, M. & Hartmann, G. (2008) RNA recognition via TLR7 and TLR8. Handbook of Experimental Pharmacology, 183, 71-86.
65. Hu, Y., Ma, D.X., Shan, N.N., Zhu, Y.Y., Liu, X.G., Zhang, L., Yu, S., Ji, C.Y. & Hou, M. (2011) Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS ONE, 10, e26522.
66. Hu, Y., Li, H., Zhang, L., Shan, B., Xu, X., Li, H., Liu, X., Xu, S., Yu, S., Ma, D., Peng, J. & Hou, M. (2012) Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Human Immunology, 6, 629-635.
67. Huber, M., Heink, S., Grothe, H., Guralnik, A., Reinhard, K., Elflein, K., Hünig, T., Mittrücker, H.W., Brüstle, A., Kamradt, T. & Lohoff, M. (2009) A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. European Journal of Immunology, 7, 1716-1725.
68. Imbach, P., Barandun, S., d'Apuzzo, V., Baumgartner, C., Hirt, A., Morell, A., Rossi, E., Schöni, M., Vest, M. & Wagner, H.P. (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 8232, 1228-1231.
69. Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D.J., Yanaba, K., Venturi, G.M., Szabolcs, P.M., Bernstein, S.H., Magro, C.M., Williams, A.D., Hall, R.P., St Clair, E.W. & Tedder, T.F. (2011) Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood, 2, 530-541.
70. Jain, N.C. & Switzer, J.W. (1981) Autoimmune thrombocytopenia in dogs and cats. The Veterinary Clinics of North America. Small Animal Practice, 2, 421-434.
71. Janeway, C.A. Jr (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology Today, 1, 11-16.
72. Jansen, P.H., Renier, W.O., de Vaan, G., Reekers, P., Vingerhoets, D.M. & Gabreëls, F.J. (1987) Effect of thymectomy on myasthenia gravis and autoimmune thrombocytopenic purpura in a 13-year-old girl. European Journal of Pediatrics, 6, 587-589.
73. Ji, L., Zhan, Y., Hua, F., Li, F., Zou, S., Wang, W., Song, D., Min, Z., Chen, H. & Cheng, Y. (2012) The ratio of treg/th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS ONE, 12, e50909.
74. Johnsen, J. (2012) Pathogenesis in immune thrombocytopenia: new insights. Hematology/The Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2012, 306-312.
75. Kaushansky, K. (2005) The molecular mechanisms that control thrombopoiesis. The Journal of Clinical Investigation, 12, 3339-3347.
76. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. (2009) IL-17 and Th17 Cells. Annual Review of Immunology, 27, 485-517.
77. Ku, F.C., Tsai, C.R., Der Wang, J., Wang, C.H., Chang, T.K. & Hwang, W.L. (2013) Stromal-derived factor-1 gene variations in pediatric patients with primary immune thrombocytopenia. European Journal of Haematology, 1, 25-30.
78. Kuwana, M. & Ikeda, Y. (2005) The role of autoreactive T cells in the pathogenesis of idiopathic thrombocytopenic purpura. International Journal of Hematology, 2, 106-112.
79. Lanzavecchia, A. (1990) Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T cells. Annual Review of Immunology, 8, 773-793.
80. Lavergne, S.N. & Trepanier, L.A. (2007) Anti-platelet antibodies in a natural animal model of sulphonamide-associated thrombocytopaenia. Platelets, 8, 595-604.
81. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M. & Hoffmann, J.A. (1996) The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell, 6, 973-983.
82. Lenschow, D.J., Walunas, T.L. & Bluestone, J.A. (1996) CD28/B7 system of T cell costimulation. Annual Review of Immunology, 14, 233-258.
83. Léon, C., Evert, K., Dombrowski, F., Pertuy, F., Eckly, A., Laeuffer, P., Gachet, C. & Greinacher, A. (2012) Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD. Blood, 14, 3333-3341.
84. Leontyev, D., Katsman, Y., Ma, X.Z., Miescher, S., Käsermann, F. & Branch, D.R. (2012) Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin. Transfusion, 8, 1799-1805.
85. Leytin, V., Mykhaylov, S., Starkey, A.F., Allen, D.J., Lau, H., Ni, H., Semple, J.W., Lazarus, A.H. & Freedman, J. (2006) Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia. British Journal of Haematology, 1, 78-82.
86. Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M. & Kuter, D.J. (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood, 12, 3241-3248.
87. Li, H., Ge, J., Zhao, H., Du, W., Xu, J., Sui, T., Ma, L., Zhou, Z., Qi, A. & Yang, R. (2011a) Association of cytotoxic T cell antigen 4 gene polymorphisms with idiopathic thrombocytopenic purpura in a Chinese population. Platelets, 1, 39-44.
88. Li, Z., Mou, W., Lu, G., Cao, J., He, X., Pan, X. & Xu, K. (2011b) Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. International Journal of Hematology, 1, 91-98.
89. Li, X., Zhong, H., Bao, W., Boulad, N., Evangelista, J., Haider, M.A., Bussel, J. & Yazdanbakhsh, K. (2012) Defective regulatory B cell compartment in patients with immune thrombocytopenia. Blood, 16, 3318-3325.
90. Liang, S.X., Pinkevych, M., Khachigian, L.M., Parish, C.R., Davenport, M.P. & Chong, B.H. (2010) Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG. Blood, 11, 1958-1960.
91. Lindahl, K.F. & Wilson, D.B. (1977) Histocompatibility antigen-activated cytotoxic T cells. II. Estimates of the frequency and specificity of precursors. Journal of Experimental Medicine, 3, 508-522.
92. Ling, Y., Cao, X.S., Yu, Z.Q., Luo, G.H., Bai, X., Su, J., Dai, L. & Ruan, C.G. (2007a) Alterations of CD4 + CD25 + regulatory T cells in patients with idiopathic thrombocytopenic purpura. Zhong-hua Xue Ye Xue Za Zhi, 3, 184-188.
93. Ling, Y., Cao, X., Yu, Z. & Ruan, C. (2007b) Circulating dendritic cells subsets and CD4 + Foxp3 + regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. European Journal of Haematology, 4, 310-316.
94. Linsley, P.S., Clark, E.A. & Ledbetter, J.A. (1990) T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proceedings of the National Academy of Sciences of the United States of America, 13, 5031-5035.
95. Liu, Y. & Linsley, P.S. (1992) Costimulation of T-cell growth. Current Opinion in Immunology, 3, 265-270.
96. Liu, B., Zhao, H., Poon, M.C., Han, Z., Gu, D., Xu, M., Jia, H., Yang, R. & Han, Z.C. (2007) Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. European Journal of Haematology, 2, 139-143.
97. Liu, L.M., Zhang, X.X., Zhao, G.S., Si, Y.J., Lin, G.Q., Zhang, Y.M., He, G.S. & Wu, D.P. (2012) Change of Th22 cells in peripheral blood of patients with primary immune thrombocytopenia and clinical implication. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 12, 1314-1316.
98. Luo, X., Tarbell, K.V., Yang, H., Pothoven, K., Bailey, S.L., Ding, R., Steinman, R.M. & Suthanthiran, M. (2007) Dendritic cells with TGF-beta1 differentiate naive CD4 + CD25- T cells into islet-protective Foxp3 + regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America, 8, 2821-2826.
99. Ma, D., Zhu, X., Zhao, P., Zhao, C., Li, X., Zhu, Y., Li, L., Sun, J., Peng, J., Ji, C. & Hou, M. (2008) Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Annals of Hematology, 11, 899-904.
100. Ma, L., Zhou, Z., Jia, H., Zhou, H., Qi, A., Li, H., Wang, H., Zhang, L. & Yang, R. (2011a) Effects of CD70 and CD11a in immune thrombocytopenia patients. Journal of Clinical Immunology, 4, 632-642.
101. Ma, L., Zhou, Z., Wang, H., Zhou, H., Zhang, D., Li, H., Qi, A. & Yang, R. (2011b) Increased expressions of DNA methyltransferases contribute to CD70 promoter hypomethylation and over expression of CD70 in ITP. Molecular Immunology, 12-13, 1525-1531.
102. Ma, L., Zhou, Z., Zhang, D., Wang, H., Li, H., Xue, F. & Yang, R. (2012) Bmi-1 regulates autoreactive CD4 + T cell survival in immune thrombocytopenia patients. Journal of Clinical Immunology, 3, 505-513.
103. Mauri, C. & Bosma, A. (2012) Immune regulatory function of B cells. Annual Review of Immunology, 30, 221-241.
104. McMillan, R., Wang, L., Tomer, A., Nichol, J. & Pistillo, J. (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood, 4, 1364-1369.
105. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A. Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 6640, 394-397.
106. Metjian, A. & Abrams, C.S. (2009) New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. Biologics: Targets & Therapy, 3, 499-513.
107. Mizutani, H., Engelman, R.W., Kurata, Y., Ikehara, S. & Good, R.A. (1993) Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB) F1 mice. Blood, 3, 837-844.
108. Molineux, G. & Newland, A. (2010) Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside. British Journal of Haematology, 1, 9-20.
109. Netea, M.G., Van Der Graaf, C.A., Vonk, A.G., Verschueren, I., Van Der Meer, J.W. & Kullberg, B.J. (2002) The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. Journal of Infectious Diseases, 10, 1483-1489.
110. Ni, H., Chen, P., Spring, C.M., Sayeh, E., Semple, J.W., Lazarus, A.H., Hynes, R.O. & Freedman, J. (2006) A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood, 7, 2976-2983.
111. Nishimoto, T., Satoh, T., Takeuchi, T., Ikeda, Y. & Kuwana, M. (2012) Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia. Experimental Hematology, 4, 279-289.
112. Nourse, J.P., Lea, R., Crooks, P., Wright, G., Tran, H., Catalano, J., Brighton, T., Grigg, A., Marlton, P. & Gandhi, M.K. (2012) The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms. Blood Coagulation & Fibrinolysis, 1, 45-50.
113. Olsson, B., Andersson, P.O., Jernås, M., Jacobsson, S., Carlsson, B., Carlsson, L.M. & Wadenvik, H. (2003) T cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nature Medicine, 9, 1123-1124.
114. Olsson, B., Ridell, B., Carlsson, L., Jacobsson, S. & Wadenvik, H. (2008) Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood, 4, 1078-1084.
115. Olsson, B., Ridell, B., Jernås, M. & Wadenvik, H. (2012) Increased number of B cells in the red pulp of the spleen in ITP. Annals of Hematology, 2, 271-277.
116. Park, S.H., Kim, J.Y., Kim, S.K., Choe, J.Y., Kim, S.G. & Ryoo, H.M. (2010) Regulatory T cells in systemic lupus erythematosus-associated thrombocytopenia: a comparison with idiopathic thrombocytopenic purpura. Lupus, 7, 888-889.
117. Pehlivan, M., Okan, V., Sever, T., Balci, S.O., Yilmaz, M., Babacan, T. & Pehlivan, S. (2011) Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets, 8, 588-595.
118. Perosa, F., Prete, M., Racanelli, V. & Dammacco, F. (2010) CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. Journal of Internal Medicine, 3, 260-277.
119. Pesmatzoglou, M., Lourou, M., Goulielmos, G.N. & Stiakaki, E. (2012) DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia. Clinical & Developmental Immunology, doi:10.1155/2012/352059.
120. Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 2, 168-186.
121. Razmara, M., Hilliard, B., Ziarani, A.K., Chen, Y.H. & Tykocinski, M.L. (2008) CTLA-4 x Ig converts naive CD4 + CD25- T cells into CD4 + CD25 + regulatory T cells. International Immunology, 4, 471-483.
122. Rocha, A.M., Souza, C., Rocha, G.A., de Melo, F.F., Clementino, N.C., Marino, M.C., Bozzi, A., Silva, M.L., Martins Filho, O.A. & Queiroz, D.M. (2011) The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica, 10, 1560-1564.
123. Rock, K.L., Benacerraf, B. & Abbas, A.K. (1984) Antigen presentation by haptenspecific B cells. I. Role of surface immunoglobulin receptors. Journal of Experimental Medicine, 160, 1102-1113.
124. Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kühne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 11, 2386-2393.
125. Roopenian, D.C. & Akilesh, S. (2007) FcRn: the neonatal Fc receptor comes of age. Nature Reviews Immunology, 9, 715-725.
126. Rossi, F., Mancusi, S., Bellini, G., Roberti, D., Punzo, F., Vetrella, S., Matarese, S.M., Nobili, B., Maione, S. & Perrotta, S. (2011) CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. Haematologica, 12, 1883-1885.
127. Rudnicka, D., Oszmiana, A., Finch, D.K., Strickland, I., Schofield, D.J., Lowe, D.C., Sleeman, M.A. & Davis, D.M. (2013) Rituximab causes a polarisation of B cells which augments its therapeutic function in NK cell-mediated antibody-dependent cellular cytotoxicity. Blood, 121, 4694-4702.
128. Saito, A., Yokohama, A., Osaki, Y., Ogawa, Y., Nakahashi, H., Toyama, K., Mitsui, T., Hashimoto, Y., Koiso, H., Uchiumi, H., Saitoh, T., Handa, H., Sawamura, M., Karasawa, M., Murakami, H., Tsukamoto, N. & Nojima, Y. (2012) Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia. European Journal of Haematology, 4, 340-349.
129. Saitoh, T., Kasamatsu, T., Inoue, M., Mitsui, T., Koiso, H., Yokohama, A., Handa, H., Matsushima, T., Tsukamoto, N., Karasawa, M., Ogawara, H., Nojima, Y. & Murakami, H. (2011) Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients. International Journal of Laboratory Hematology, 5, 526-532.
130. Sakaguchi, S. (2004) Naturally arising CD4_ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology, 22, 531-562.
131. Sakaguchi, S., Miyara, M., Costantino, C.M. & Hafler, D.A. (2010) FOXP3 + regulatory T cells in the human immune system. Nature Reviews Immunology, 7, 490-500.
132. Sakakura, M., Wada, H., Tawara, I., Nobori, T., Sugiyama, T., Sagawa, N. & Shiku, H. (2007) Reduced Cd4 + Cd25 + T cells in patients with idiopathic thrombocytopenic purpura. Thrombosis Research, 2, 187-193.
133. Saleh, M.N., Moore, D.L., Lee, J.Y. & LoBuglio, A.F. (1989) Monocyte-platelet interaction in immune and nonimmune thrombocytopenia. Blood, 4, 1328-1331.
134. Samuelsson, A., Towers, T.L. & Ravetch, J.V. (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 5503, 484-486.
135. Sarpatwari, A., Bussel, J.B., Ahmed, M., Erqou, S., Semple, J.W., Newland, A.C., Bennett, D., Pharoah, P. & Provan, D. (2011) Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology, 4, 243-248.
136. Schwab, I., Seeling, M., Biburger, M., Aschermann, S., Nitschke, L. & Nimmerjahn, F. (2012a) B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo. European Journal of Immunology, 12, 3302-3309.
137. Schwab, I., Biburger, M., Krönke, G., Schett, G. & Nimmerjahn, F. (2012b) IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1. European Journal of Immunology, 4, 826-830.
138. Sedger, L.M., Katewa, A., Pettersen, A.K., Osvath, S.R., Farrell, G.C., Stewart, G.J., Bendall, L.J. & Alexander, S.I. (2010) Extreme
139. Segel, G.B. & Feig, S.A. (2009) Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura. Pediatric Blood & Cancer, 3, 318-324.
140. Semple, J.W. (2009) Infections, antigen-presenting cells, T cells, and immune tolerance: their role in the pathogenesis of immune thrombocytopenia. Hematology/oncology Clinics of North America, 6, 1177-1192.
141. Semple, J.W. (2010) Animal models of immune thrombocytopenia (ITP). Annals of Hematology, 1, 37-44.
142. Semple, J.W. (2012) Bregging rights in ITP. Blood, 16, 3169.
143. Semple, J.W. & Freedman, J. (1991) Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood, 10, 2619-2625.
144. Semple, J.W. & Provan, D. (2012) The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Current Opinion in Hematology, 5, 357-362.
145. Semple, J.W., Bruce, S. & Freedman, J. (1991) Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. American Journal of Hematology, 4, 258-262.
146. Semple, J.W., Milev, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V. & Freedman, J. (1996) Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T cell reactivity. Blood, 10, 4245-4254.
147. Semple, J.W., Aslam, R., Kim, M., Speck, E.R. & Freedman, J. (2007) Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood, 11, 4803-4805.
148. Semple, J.W., Provan, D., Garvey, M.B. & Freedman, J. (2010) Recent progress in understanding the pathogenesis of immune thrombocytopenia. Current Opinion in Hematology, 6, 590-595.
149. Semple, J.W., Italiano, J.E. Jr & Freedman, J. (2011) Platelets and the immune continuum. Nature Reviews Immunology, 4, 264-274.
150. Shulman, N.R., Weinrach, R.S., Libre, E.P. & Andrews, H.L. (1965) The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Transactions of the Association of American Physicians, 78, 374-390.
151. Siragam, V., Crow, A.R., Brinc, D., Song, S., Freedman, J. & Lazarus, A.H. (2006) Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nature Medicine, 6, 688-692.
152. Smith, E.C., Thon, J.N., Devine, M.T., Lin, S., Schulz, V.P., Guo, Y., Massaro, S.A., Halene, S., Gallagher, P., Italiano, J.E. Jr & Krause, D.S. (2012) MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation. Blood, 11, 2317-2329.
153. Sollazzo, D., Trabanelli, S., Curti, A., Vianelli, N., Lemoli, R.M. & Catani, L. (2011) Circulating CD4 + CD161 + CD196 + Th17 cells are not increased in immune thrombocytopenia. Haematologica, 4, 632-634.
154. Sood, R., Wong, W., Gotlib, J., Jeng, M. & Zehnder, J.L. (2008) Gene expression and pathway analysis of immune thrombocytopenic purpura. British Journal of Haematology, 1, 99-103.
155. Stasi, R. (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Seminars in Hematology, 2, 170-179.
156. Stasi, R., Del Poeta, G., Stipa, E., Evangelista, M.L., Trawinska, M.M., Cooper, N. & Amadori, S. (2007) Response to B cell depleting therapy with rituximab reverts the abnormalities of T cell subsets in patients with idiopathic thrombocytopenic purpura. Blood, 8, 2924-2930.
157. Stasi, R., Cooper, N., Del Poeta, G., Stipa, E., Laura Evangelista, M., Abruzzese, E. & Amadori, S. (2008a) Analysis of regulatory T cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood, 4, 1147-1150.
158. Stasi, R., Evangelista, M.L., Stipa, E., Buccisano, F., Venditti, A. & Amadori, S. (2008b) Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thrombosis and Haemostasis, 1, 4-13.
159. Stasi, R., Bosworth, J., Rhodes, E., Shannon, M.S., Willis, F. & Gordon-Smith, E.C. (2010) Thrombopoietic agents. Blood Reviews, 4-5, 179-190.
160. Stuart, M.J., Tomar, R.H., Miller, M.L. & Davey, F.R. (1978) Chronic idiopathic thrombocytopenic purpura. A familial immunodeficiency syndrome. The Journal of the American Medical Association, 10, 939-942.
161. Takeda, K., Kaisho, T. & Akira, S. (2003) Toll-like receptors. Annual Review of Immunology, 21, 335-376.
162. Tesmer, L.A., Lundy, S.K., Sarkar, S. & Fox, D.A. (2008) Th17 cells in human disease. Immunological Reviews, 223, 87-113.
163. Tremblay, T., Aubin, E., Lemieux, R. & Bazin, R. (2007) Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice. British Journal of Haematology, 2, 297-302.
164. Turvey, S.E. & Broide, D.H. (2010) Innate immunity. The Journal of Allergy and Clinical Immunology, 125, S24-S32.
165. Uhrberg, M., Valiante, N.M., Shum, B.P., Shilling, H.G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L.L. & Parham, P. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity, 6, 753-763.
166. Unanue, E.R. (1984) Antigen-presenting function of the macrophage. Annual Review of Immunology, 2, 395-428.
167. Wakisaka, G., Yasunaga, K., Kuramoto, A., Okuma, M. & Furukawa, H. (1964) Experimental study of Immune Thrombocytopenia induced by quinidine. Arerugi, 13, 686-689.
168. Wang, X.P., Qiu, Y.S., Hao, G.P. & Zhu, L. (2011) Levels of regulatory T cells in peripheral blood of children with idiopathic thrombocytopenic purpura. Zhongguo Dang Dai Er Ke Za Zhi, 4, 282-284.
169. Ware, R.E. & Howard, T.A. (1993) Phenotypic and clonal analysis of T cells in childhood immune thrombocytopenic purpura. Blood, 7, 2137-2142.
170. Waters, A.H. (1992) Autoimmune thrombocytopenia: clinical aspects. Seminars in Hematology, 1, 18-25.
171. Watts, C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annual Review of Immunology, 15, 821-850.
172. Weaver, C.T. & Hatton, R.D. (2009) Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nature Reviews Immunology, 12, 883-889.
173. Webster, M.L., Sayeh, E., Crow, M., Chen, P., Nieswandt, B., Freedman, J. & Ni, H. (2006) Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood, 3, 943-946.
174. Wendling, F., Maraskovsky, E., Debili, N., Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D. & Vainchenker, W. (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 6481, 571-574.
175. Wilkins, R.J., Hurvitz, A.I. & Dodds-Laffin, W.J. (1973) Immunologically mediated thrombocytopenia in the dog. Journal of the American Veterinary Medical Association, 3, 277-282.
176. Wilson, N.J., Boniface, K., Chan, J.R., McKenzie, B.S., Blumenschein, W.M., Mattson, J.D., Basham, B., Smith, K., Chen, T., Morel, F., Lecron, J.C., Kastelein, R.A., Cua, D.J., McClanahan, T.K., Bowman, E.P. & de Waal Malefyt, R. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology, 9, 950-957.
177. Wright, J.F., Blanchette, V.S., Wang, H., Arya, N., Petric, M., Semple, J.W., Chia, W.K. & Freedman, J. (1996) Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). British Journal of Haematology, 1, 145-152.
178. Xu, J., Huang, Y., Tao, J., Zhou, Z., Chen, Z., Ge, J. & Yang, R. (2010) An FcgammaRIIb transmembrane polymorphism in Chinese ITP patients. Platelets, 6, 479-485.
179. Yacobovich, J., Revel-Vilk, S. & Tamary, H. (2013) Childhood immune thrombocytopenia-who will spontaneously recover? Seminars in Hematology, 50, S71-S74.
180. Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnaksu, R., Hosokawa, H., Hasegawa, A., Motohashi, S., Iwama, A. & Nakayama, T. (2008) Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. Journal of Experimental Medicine, 5, 1109-1120.
181. Yang, Q., Xu, S., Li, X., Wang, B., Wang, X., Ma, D., Yang, L., Peng, J. & Hou, M. (2011) Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo. PLoS ONE, 7, e22708.
182. Yoh, K., Morito, N., Ojima, M., Shibuya, K., Yamashita, Y., Morishima, Y., Ishii, Y., Kusakabe, M., Nishikii, H., Fujita, A., Matsunaga, E., Okamura, M., Hamada, M., Suto, A., Nakajima, H., Shibuya, A., Yamagata, K. & Takahashi, S. (2012) Overexpression of RORγt under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice. European Journal of Immunology, 8, 1999-2009.
183. Yu, J., Heck, S., Patel, V., Levan, J., Yu, Y., Bussel, J.B. & Yazdanbakhsh, K. (2008) Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood, 4, 1325-1328.
184. Yu, H., Liu, Y., Han, J., Yang, Z., Sheng, W., Dai, H., Wang, Y., Xia, T. & Hou, M. (2011) TLR7 regulates dendritic cell-dependent B cell responses through BlyS in immune thrombocytopenic purpura. European Journal of Haematology, 1, 67-74.
185. Zhang, J., Ma, D., Zhu, X., Qu, X., Ji, C. & Hou, M. (2009a) Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica, 9, 1326-1329.
186. Zhang, X.L., Peng, J., Sun, J.Z., Liu, J.J., Guo, C.S., Wang, Z.G., Yu, Y., Shi, Y., Qin, P., Li, S.G., Zhang, L.N. & Hou, M. (2009b) De novo induction of platelet-specific CD4(+)CD25(+) regulatory T cells from CD4(+)CD25(-) cells in patients with idiopathic thrombocytopenic purpura. Blood, 11, 2568-2577.
187. Zhang, B., Lo, C., Shen, L., Sood, R., Jones, C., Cusmano-Ozog, K., Park-Snyder, S., Wong, W., Jeng, M., Cowan, T., Engleman, E.G. & Zehnder, J.L. (2011) The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood, 117, 4569-4579.
188. Zhong, H., Bao, W., Li, X., Miller, A., Seery, C., Haq, N., Bussel, J. & Yazdanbakhsh, K. (2012) CD16 + monocytes control T cell subset development in immune thrombocytopenia. Blood, 16, 3326-3335.
189. Zhou, Z.H., Zhuang, L., Li, X.Y., Li, J. & Luo, S.K. (2010) The role of B cell-activating factor secreted by peripheral blood monocyte-derived dendritic cell in chronic idiopathic thrombocytopenic purpura. Zhonghua Xue Ye Xue Za Zhi, 9, 599-602.
190. Zhou, H., Qi, A.P., Li, H.Y., Ma, L., Xu, J.H., Xue, F., Lu, S.H., Zhao, Q.J., Zhou, Z.P. & Yang, R.C. (2012) CD72 gene expression in immune thrombocytopenia. Platelets, 8, 638-644.
191. Zou, W. & Restifo, N.P. (2010) T(H)17 cells in tumour immunity and immunotherapy. Nature Reviews Immunology, 4, 248-256.